Literature DB >> 25952756

Genotype-phenotype analysis of von Hippel-Lindau syndrome in fifteen Indian families.

Narendranath Vikkath1,2, Sindhu Valiyaveedan3, Sheela Nampoothiri4, Natasha Radhakrishnan5, Gopal S Pillai5, Vasantha Nair6, Ginil Kumar Pooleri7, Georgie Mathew7, Krishnakumar N Menon2, Prasanth S Ariyannur8,9, Ashok B Pillai10,11.   

Abstract

The general prevalence of the familial multi-organ tumor disorder, von Hippel-Lindau syndrome (VHL), was estimated to be 1 in 25-40,000 in western studies two decades back. Few studies were done in Indian sub-continent, amidst a surge in clinical reports on VHL specific manifestations. The syndrome is correlated with mutations of the gene VHL (located in Chr 3p25.3). We aimed to conduct a prospective case series describing phenotypic and genotypic characteristics in Indian population. The VHL-specific clinical and radiological features were collected from patients and family members. Genotypic changes such as deletion/duplication or point mutation in the VHL locus were identified using sequencing and MLPA. Thirty-one subjects, from fifteen families with diagnosed VHL, were included in the study. Multicystic pancreas was found in 71% (22/31), CNS hemangioblastoma in 68% (21/31), renal cell carcinoma and retinal angiomas in 23% (7/31) each, pheochromocytoma in 9.7% (3/31) of the population and endolymphatic sac tumor in one subject. Four families (9 subjects) had full length deletion of VHL, three families (4 subjects) had a deletion of exon 3, eight families (18 subjects) had different exonic, splice-site and intronic point mutations and one subject had a de novo in-frame indel in exon 1. Multicystic pancreas and CNS hemangioblastomas were the most common manifestations in our population. The phenotypic expression patterns in terms of tumorigenesis, tissue tropism and penetrance in comparison to the genotypic features were found to be different from previous correlative studies.

Entities:  

Keywords:  Genotype–Phenotype correlation; India; Mutation; VHL; von Hippel–Lindau syndrome

Mesh:

Substances:

Year:  2015        PMID: 25952756     DOI: 10.1007/s10689-015-9806-z

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  46 in total

1.  A 10-year retrospective study of hemangioblastomas of the central nervous system with reference to von Hippel-Lindau (VHL) disease.

Authors:  Somanath Padhi; Rajlaxmi Sarangi; Sundaram Challa; Priyatamjee Bussary; Manas K Panigrahi; Anirudh K Purohit
Journal:  J Clin Neurosci       Date:  2011-05-12       Impact factor: 1.961

2.  Intracranial hemangioblastomas: an institutional experience.

Authors:  Srinivas Dwarakanath; Ashish Suri; Bhavani Shanker Sharma; Veer Singh Mehta
Journal:  Neurol India       Date:  2006-09       Impact factor: 2.117

3.  Genotype-phenotype correlation in von Hippel-Lindau disease with retinal angiomatosis.

Authors:  Wai T Wong; Elvira Agrón; Hanna R Coleman; George F Reed; Karl Csaky; James Peterson; Gladys Glenn; W Marston Linehan; Paul Albert; Emily Y Chew
Journal:  Arch Ophthalmol       Date:  2007-02

Review 4.  Molecular basis of the VHL hereditary cancer syndrome.

Authors:  William G Kaelin
Journal:  Nat Rev Cancer       Date:  2002-09       Impact factor: 60.716

5.  Genotype-phenotype correlations in VHL exon deletions.

Authors:  Alisdair McNeill; Eleanor Rattenberry; Richard Barber; Pip Killick; Fiona MacDonald; Eamonn R Maher
Journal:  Am J Med Genet A       Date:  2009-10       Impact factor: 2.802

Review 6.  Functions of the von Hippel-Lindau tumour suppressor protein.

Authors:  W G Kaelin; O Iliopoulos; K M Lonergan; M Ohh
Journal:  J Intern Med       Date:  1998-06       Impact factor: 8.989

7.  Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function.

Authors:  C E Stebbins; W G Kaelin; N P Pavletich
Journal:  Science       Date:  1999-04-16       Impact factor: 47.728

8.  Von Hippel-Lindau disease: a genetic study.

Authors:  E R Maher; L Iselius; J R Yates; M Littler; C Benjamin; R Harris; J Sampson; A Williams; M A Ferguson-Smith; N Morton
Journal:  J Med Genet       Date:  1991-07       Impact factor: 6.318

9.  pVHL modification by NEDD8 is required for fibronectin matrix assembly and suppression of tumor development.

Authors:  Natalie H Stickle; Jacky Chung; Jeffery M Klco; Richard P Hill; William G Kaelin; Michael Ohh
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

Review 10.  Regulation of WASP/WAVE proteins: making a long story short.

Authors:  Guillaume Bompard; Emmanuelle Caron
Journal:  J Cell Biol       Date:  2004-09-27       Impact factor: 10.539

View more
  7 in total

1.  The Expression of VHL (Von Hippel-Lindau) After Traumatic Spinal Cord Injury and Its Role in Neuronal Apoptosis.

Authors:  Jie Hao; Xiaoqing Chen; Ting Fu; Jie Liu; Mingchen Yu; Wei Han; Shuang He; Rong Qian; Feng Zhang
Journal:  Neurochem Res       Date:  2016-06-21       Impact factor: 3.996

2.  Genotype phenotype correlation in Asian Indian von Hippel-Lindau (VHL) syndrome patients with pheochromocytoma/paraganglioma.

Authors:  Nilesh Lomte; Sanjeet Kumar; Vijaya Sarathi; Reshma Pandit; Manjunath Goroshi; Swati Jadhav; Anurag R Lila; Tushar Bandgar; Nalini S Shah
Journal:  Fam Cancer       Date:  2018-07       Impact factor: 2.375

3.  A meta-analysis of different von Hippel Lindau mutations: are they related to retinal capillary hemangioblastoma?

Authors:  Fatemeh Azimi; Ali Aghajani; Golnaz Khakpour; Samira Chaibakhsh
Journal:  Mol Genet Genomics       Date:  2022-08-25       Impact factor: 2.980

Review 4.  Pheochromocytomas and paragangliomas in von Hippel-Lindau disease: not a needle in a haystack.

Authors:  João Castro-Teles; Bernardo Sousa-Pinto; Sandra Rebelo; Duarte Pignatelli
Journal:  Endocr Connect       Date:  2021-10-27       Impact factor: 3.335

5.  Fibronectin protein expression in renal cell carcinoma in correlation with clinical stage of tumour.

Authors:  Sandeep Kondisetty; Krishnakumar N Menon; Ginil Kumar Pooleri
Journal:  Biomark Res       Date:  2018-07-11

6.  New Insights Into Pheochromocytoma Surveillance of Young Patients With VHL Missense Mutations.

Authors:  Gustavo F C Fagundes; Janaina Petenuci; Delmar M Lourenco; Ericka B Trarbach; Maria Adelaide A Pereira; Joya Emilie Correa D'Eur; Ana O Hoff; Antonio M Lerario; Maria Claudia N Zerbini; Sheila Siqueira; Fernando Yamauchi; Victor Srougi; Fabio Y Tanno; Jose Luis Chambo; Ana Claudia Latronico; Berenice B Mendonca; Maria Candida B V Fragoso; Madson Q Almeida
Journal:  J Endocr Soc       Date:  2019-07-02

7.  Frequent Mutations of VHL Gene and the Clinical Phenotypes in the Largest Chinese Cohort With Von Hippel-Lindau Disease.

Authors:  Baoan Hong; Kaifang Ma; Jingcheng Zhou; Jiufeng Zhang; Jiangyi Wang; Shengjie Liu; Zhongyuan Zhang; Lin Cai; Ning Zhang; Kan Gong
Journal:  Front Genet       Date:  2019-09-18       Impact factor: 4.599

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.